|
Delayed
NYSE
18:57:49 16/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 29.98 USD | -2.40% |
|
-5.59% | -7.24% |
| Current month | -7.66% | ||
| 1 month | -15.15% |
Main features
| US46436E3532 | Fees | 0.47% | Dividend Policy | Distribution | |
|---|---|---|---|---|---|
| Currency | USD | AuM (GBP) | 6.68M | Replication Method | Direct (Physical) |
| Number of securities | 60 | AuM evolution | - | Date of creation | 23/08/2022 |
| Name |
Off-Hours Price |
Change |
Weight | |
|---|---|---|---|---|
 | 157.52USD | -2.64% | 4.89% | |
| 245.21USD | -1.22% | 4.75% | |
| 33.61USD | -2.10% | 3.98% | |
| 59.31USD | -2.75% | 3.93% | |
| 39.82USD | -2.03% | 3.91% | |
| 19.18USD | -2.69% | 3.89% | |
| 235.36USD | +0.01% | 3.88% | |
| 40.67USD | +1.42% | 3.79% | |
| 819.32USD | -3.18% | 3.73% | |
| 136.02USD | -0.68% | 3.65% | |
Easily sort and filter through all available ETFs
Access the ETF ScreenerEconomic news
In partnership with
Investment objective
| Asset Classes | Stocks |
|---|---|
| Geographical Focus | - |
| Theme and Sector | Healthcare Technology & Innovation |
The iShares Neuroscience and Healthcare ETF (the Fund) seeks to track the investment results of an index composed of U.S. and non-U.S. companies that could benefit from the growth and innovation in neuroscience.
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/10/26 | US$29.98 | -2.40% | 441 |
| 15/10/26 | US$30.72 | +2.53% | 2,847 |
| 14/10/26 | US$29.96 | -1.12% | 615 |
| 13/10/26 | US$30.30 | -3.61% | 625 |
| 12/10/26 | US$31.43 | -1.02% | 2,315 |
- Stock Market
- ETF
- IBRN ETF
Select your edition
All financial news and data tailored to specific country editions
